Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
The ESPRIT Study: Estrogen Suppression and Perfusion Reserve With Aromatase-Inhibitor Treatment in Premenopausal Women With Breast Cancer
Sponsor: National Cancer Institute (NCI)
Listed as NCT03505736, this observational or N/A phase trial focuses on Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage IA Breast Cancer AJCC v8 and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 16 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
16 versions recorded-
Feb 2026 — Present [monthly]
Completed
-
Sep 2024 — Feb 2026 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 11 earlier versions
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting
-
Sep 2019 — Nov 2019 [monthly]
Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Recruiting
-
Apr 2019 — Jun 2019 [monthly]
Recruiting
-
Jul 2018 — Apr 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .